دورية أكاديمية
Antitumor effect of Iso-mukaadial acetate on MCF-7 breast cancer mice xenograft model.
العنوان: | Antitumor effect of Iso-mukaadial acetate on MCF-7 breast cancer mice xenograft model. |
---|---|
المؤلفون: | Raphela-Choma PP; Department of Biochemistry, University of Johannesburg, Corner Kingsway and University Road, Auckland Park, Johannesburg, 2092, South Africa. portiapheladi22@gmail.com., Lukhwareni R; Department of Biochemistry, University of Johannesburg, Corner Kingsway and University Road, Auckland Park, Johannesburg, 2092, South Africa., Simelane MBC; Department of Biochemistry, University of Johannesburg, Corner Kingsway and University Road, Auckland Park, Johannesburg, 2092, South Africa., Motadi LR; Department of Biochemistry, University of Johannesburg, Corner Kingsway and University Road, Auckland Park, Johannesburg, 2092, South Africa., Choene MS; Department of Biochemistry, University of Johannesburg, Corner Kingsway and University Road, Auckland Park, Johannesburg, 2092, South Africa. |
المصدر: | Scientific reports [Sci Rep] 2024 Jun 14; Vol. 14 (1), pp. 13744. Date of Electronic Publication: 2024 Jun 14. |
نوع المنشور: | Journal Article |
اللغة: | English |
بيانات الدورية: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: London : Nature Publishing Group, copyright 2011- |
مواضيع طبية MeSH: | Xenograft Model Antitumor Assays* , Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Apoptosis*/drug effects , Mice, Nude*, Animals ; Humans ; Female ; Mice ; MCF-7 Cells ; Antineoplastic Agents/pharmacology ; Cell Proliferation/drug effects |
مستخلص: | Antitumor drugs used today have shown significant efficacy and are derived from natural products such as plants. Iso-mukaadial acetate (IMA) has previously been shown to possess anticancer properties by inducing apoptosis. The purpose of this study was to investigate the therapeutic effect of IMA in the breast cancer xenograft mice model. Female athymic nude mice were used and inoculated with breast cancer cells subcutaneously. Untreated group one served as a negative control and positive control group two (cisplatin) was administered intravenously. IMA was administered orally to group three (100 mg/kg) and group four (300 mg/kg). Blood was collected (70 μL) from the tail vein on day zero, day one and day three. Tumor regression was measured every second day and body mass was recorded each day. Estimation of serum parameters for renal indices was examined using a creatinine assay. Histopathological analysis was conducted to evaluate morphological changes of liver, kidney, and spleen tissues before and after compound administration under a fluorescence light microscope. Histopathological analysis of tumors was conducted before and after compound administration. Apoptotic analysis using the TUNEL system was conducted on liver, kidney, and spleen tissues. Tumor shrinkage and reduction in body mass were observed after treatment with IMA. Serum creatinine was slightly elevated after treatment with IMA at a dosage of 100 and 300 mg/kg. Histopathological results of the liver exhibited no changes before and after IMA while the kidney and spleen tissues showed changes in the cellular structure. IMA showed no cytotoxic effect on the tumor cells, and cell proliferation was observed. Apoptotic assay stain with TUNEL showed apoptotic cells in spleen tissue and kidney but no apoptotic cells were observed in liver tissue section treated with IMA. IMA showed clinical toxic signs that resulted in the suffering and death of the mice immediately after IMA administration. Histopathology of tumor cells showed that IMA did not inhibit cell proliferation and no cellular damage was observed. Therefore, based on the results obtained, we cannot make any definitive conclusion on the complete effect of IMA in vivo. IMA is toxic, poorly soluble, and not safe to use in animal studies. The objective of the study was not achieved, and the hypothesis was rejected. (© 2024. The Author(s).) |
References: | Carcinogenesis. 2005 May;26(5):968-75. (PMID: 15705600) Ren Fail. 2007;29(1):23-7. (PMID: 17365906) Crit Care. 2016 Sep 27;20(1):299. (PMID: 27670788) Biochem Pharmacol. 2022 Oct;204:115209. (PMID: 35973582) Anticancer Drugs. 2007 Mar;18(3):311-5. (PMID: 17264764) Malar J. 2011 Mar 15;10 Suppl 1:S1. (PMID: 21411010) J Evid Based Complementary Altern Med. 2017 Oct;22(4):982-995. (PMID: 28359161) Kidney Int. 2007 Jan;71(1):74-8. (PMID: 17082757) Front Pharmacol. 2023 Jan 16;13:1072760. (PMID: 36726787) Bioorg Med Chem. 2019 Jun 15;27(12):2546-2552. (PMID: 30910472) Breast Cancer Res Treat. 2023 Feb;197(3):647-659. (PMID: 36538247) Malar J. 2018 Aug 15;17(1):296. (PMID: 30111328) Asian Pac J Cancer Prev. 2013;14(1):409-12. (PMID: 23534763) Diabetes Obes Metab. 2019 Nov;21(11):2368-2383. (PMID: 31297976) Acta Biochim Biophys Sin (Shanghai). 2012 Feb;44(2):147-53. (PMID: 22126905) Nucl Med Biol. 2018 Nov;66:18-25. (PMID: 30170197) Perm J. 2004 Winter;8(1):51-3. (PMID: 26704606) Curr Cancer Drug Targets. 2020;20(8):586-602. (PMID: 32418525) Med Oncol. 2005;22(2):129-38. (PMID: 15965275) |
معلومات مُعتمدة: | 1229861 TTK200316509644 |
فهرسة مساهمة: | Keywords: Antitumor; Apoptosis; Athymic-nude mice; Breast cancer; Iso-mukaadial acetate; MCF-7 |
المشرفين على المادة: | 0 (Antineoplastic Agents) |
تواريخ الأحداث: | Date Created: 20240614 Date Completed: 20240615 Latest Revision: 20240618 |
رمز التحديث: | 20240618 |
مُعرف محوري في PubMed: | PMC11178819 |
DOI: | 10.1038/s41598-024-64474-x |
PMID: | 38877067 |
قاعدة البيانات: | MEDLINE |
تدمد: | 2045-2322 |
---|---|
DOI: | 10.1038/s41598-024-64474-x |